SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotify shares are drawing attention after rising sharply despite a Q3 revenue and EPS miss, with traders focusing instead on premium subscriber growth, stronger gross margin, and an upbeat Q4 operating-income outlook. The move has surprised skeptics, while bullish traders point to the guidance and operating metrics as support for the rally.

Compound (COMP) is a cryptocurrency and operates on the Ethereum platform. Compound has a current supply of 10,000,000 with 9,999,999.99995246 in circulation. The last known price of Compound is 20.49527411 USD and is down -2.02 over the last 24 hours. It is currently trading on 652 active market(s) with $25,001,434.49 traded over the last 24 hours. More information can be found at https://www.compound.xyz/.

Compound

Discussion centers on Compounds institutional push, including a reported treasury-backed finance program, new leadership, an institutional market launch, and V4 plans tied to tokenized assets. Bulls see this and COMPs limited supply as potential catalysts, while skeptics highlight its weak, lagging price action;

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by growth in Dupixent and Eylea HD, is driving a sharp share-price gain and breakout discussion. Traders are broadly bullish on the follow-through and new highs, while some are watching for a pullback or gap retest.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Traders are discussing a rotation from volatile tech and AI stocks toward dividend-paying value funds, with many viewing SCHD as a defensive holding and adding shares for income and long-term investing. Others point to rising Treasury yields and recent pullbacks as risks, while some expect investor flows to return to tech.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

IBKR is drawing attention after its earnings report prompted a selloff despite growth in client accounts and interest income; traders are focused on weaker trading activity and competition, while others view the firms profitability and dividend increase as positives. The reaction reflects debate over whether slower activity outweighs the companys strong underlying business.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has raised concerns about competition for Precigens PAPZIMEOS. Traders debate the threat, weighing Inovios potential treatment advantages against Precigens first-mover lead and full-approval status, as well as questions about the rivals commercialization and reimbursement path.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Shares are under pressure after Schwabs Q3 revenue fell slightly short of estimates despite an earnings beat, with traders focused on whether the prolonged decline can hold near $84. Some see an oversold buying opportunity, while others remain concerned about continued weakness and recurring platform outages.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies stronger-than-expected third-quarter results and raised 2026 outlook, supported by growth in its immunology portfolio, are driving attention. Traders are weighing the earnings beat against the stocks recent run-up, with some cheering the results and others describing the reaction as profit-taking or sell the news.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

A broader Nasdaq and technology-stock selloff is weighing on QQQI, prompting many holders to buy the dip for its monthly income while others raise cash or question whether the distributions offset price declines and covered-call upside limits.

Carpenter Technology Corp. engages in the manufacturing, fabrication, and distribution of specialty metals. It operates through the Specialty Alloys Operations and Performance Engineered Products segments. The Specialty Alloys Operations segment is composed of its major premium alloy and stainless-steel manufacturing operations. The Performance Engineered Products segment includes the Dynamet titanium, Carpenter Additive, and the Latrobe and Mexico distribution businesses. The company was founded by James Carpenter in 1889 and is headquartered in Philadelphia, PA.

Carpenter Technology Corp.

Carpenter Technologys quarterly report has driven a sharp selloff despite an earnings beat: traders point to missed revenue expectations, a largely flat near-term outlook, and negative free cash flow amid higher expansion spending. Bulls view the decline as an oversold buying opportunity, while bears question the earnings outlook and note weakness across aerospace and specialty-materials stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why the Market Dipped But Kraft Heinz (KHC) Gained Today

Kraft Heinz (KHC) reached $24.34 at the closing of the latest trading day, reflecting a +1.84% change compared to its last close.

Kraft Heinz vs. Coca-Cola: Stagnant Versus Growing Revenue Trends in Consumer Goods

Key PointsCoca-Cola currently presents a stronger revenue profile than Kraft Heinz, as it consistently records higher overall sales totals, including its peak for the quarter ended July 2026, while maintaining year-over-year gains...

Kraft Heinz to Report Q3 Earnings: Essential Insights for Investors

KHC expects to post weaker Q3 sales and earnings amid soft volumes, cautious consumer spending and rising costs, while strategic investments may offer support.

Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for

Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kraft Heinz vs. Monster Beverage: Investors Should Consider One's Stagnant Sales Against the Other's Growing Revenue Before Buying Shares

Key PointsKraft Heinz maintains a clear advantage in total sales generation, but Monster Beverage appears stronger right now when evaluating its overall pace of expansion and recent upward trajectory...

Analysts Estimate Kraft Heinz (KHC) to Report a Decline in Earnings: What to Look Out for

Kraft Heinz (KHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kraft Heinz (KHC) Declines More Than Market: Some Information for Investors

In the latest trading session, Kraft Heinz (KHC) closed at $24.8, marking a -1.16% move from the previous day.

What's Wrong With Kraft Heinz Stock?

Key PointsKraft Heinz's stock price is down more than 35% over the past five years...

Can Campbell's Digital Marketing Strategy Fuel Everyday Meal Sales?

CPB is ramping up digital and AI-enabled marketing to boost everyday meal sales, leveraging recipe inspiration and rising demand for affordable home cooking.

Kraft Heinz (KHC) Gains As Market Dips: What You Should Know

In the latest trading session, Kraft Heinz (KHC) closed at $23.71, marking a +1.83% move from the previous day.

• Reported GAAP EPS of -$4.60 up 30.30% YoY
• Reported revenue of $6.26B down -1.42% YoY
• For fiscal year 2026, The Kraft Heinz Company expects Organic Net Sales down 0.5 percent to 2.0 percent, Adjusted EPS of $2.03 to $2.09, and Free Cash Flow Conversion of 110 percent.

The Kraft Heinz Company faced a significant operating loss from impairment charges, while increased advertising, manufacturing inflation, and volume declines in key categories pressured adjusted operating income and overall performance.

The Kraft Heinz Company delivered strong cash flow growth and robust performance in Emerging Markets, while increasing strategic investments to support brand resonance and position the business for future growth.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

KHC, CLX, HSY Stocks In Focus: Consumer Staples Lag The Market, But Analyst Sees Potential In These Three Names 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Morningstar said alcoholic beverages and packaged goods appear undervalued as consumers seek cheaper options.&nbsp;</li><li>Kraft Heinz trades 40% below Morningstar’s $41 fair value estimate.&nbsp;</li><li>Clorox trades 45% below Morningstar’s $154 fair value estimate, with key brands gaining market share.&nbsp;</li></ul><p>Consumer defensive stocks lagged the broader market in the third quarter, but Morningstar sees value in the sector as valuations remain attractive. Kraft Heinz (KHC), Clorox Co. (CLX) and Hershey Co. (HSY) stand out as top picks, trading at discounts of 40%, 45% and 30%, respectively, to Morningstar’s fair value estimates.&nbsp;</p><h2 class="st-heading-2">Alcohol And Packaged Goods Lead On Valuation</h2><p>Erin Lash, director of consumer equity research at Morningstar, said food, beverage, and household product stocks could rise as companies adjust to consumers spending less.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261011_105234323_6080b4a8cc.png" alt="koyfin_20261011_105234323.png" width="2400" height="1240"></figure><p>Lash said alcoholic beverage producers trade at an average 24% discount to Morningstar's fair value estimates, while consumer packaged goods companies sit at a 20% discount. The broader consumer defensive group also appears undervalued, with the median stock trading approximately 5% below its estimated worth.</p><h2 class="st-heading-2">Higher Transportation Costs Complicate Pricing</h2><p>Higher trucking and warehousing costs are squeezing company profits, while U.S. food prices have risen 33% since 2019, said Lash. As shoppers become more price-conscious and switch to cheaper options, companies face pressure to control costs and justify further price increases.&nbsp;</p><p>Higher prices have hurt sales volumes for packaged goods companies. Quarterly organic sales volumes have fallen by an average of 0.2% since early 2023, compared with nearly 2% growth from 2018 to late 2021. Morningstar says the decline may be slowing as companies offer products that customers want.&nbsp;</p><h2 class="st-heading-2">Kraft Heinz Trades At 40% Discount: Morningstar&nbsp;</h2><p>Kraft Heinz trades at a 40% discount to Morningstar's $41 fair value estimate and offers a dividend yield close to 7%. The company dropped its planned separation earlier this year and committed another $700 million to brand development. Morningstar views the decision positively, noting that about 70% of the company's sauces portfolio is gaining market share.</p><p>RBC Capital started coverage of Kraft Heinz last month with an ‘Outperform’ rating and a $32 price target, implying a 435 upside to the stock’s close on Friday. The analyst said the company is making major changes that are expected to show their full impact in 2027 and expects Kraft Heinz’s organic revenue and earnings to exceed analysts’ average estimates in 2027.&nbsp;</p><p><a href="https://stocktwits.com/symbol/KHC">Kraft Heinz stock</a> edged 0.04% higher overnight, ahead of Monday. The stock slumped 10% in September, recording its worst month in four years.&nbsp;</p><h2 class="st-heading-2">Morningstar Sees Upside For Clorox, Hershey&nbsp;</h2><p>Clorox trades 45% below Morningstar’s $154 fair value estimate. The company has gained market share in Hidden Valley Ranch and Glad trash bags, which together generate about one-fifth of its sales. Lash expects efficiency improvements to help support continued brand investment despite recent operating challenges.</p><p>However, on Oct.1, TD Cowen cut its price target on the household products maker to $85 from $90 and maintained a ‘Hold’ rating. The firm lowered its FY27 earnings forecast to $5.55 per share, below Clorox’s earlier estimate of $5.70 to $6.00, citing higher shipping and oil costs and continued weakness in several business areas.&nbsp;<a href="https://stocktwits.com/symbol/CLX">Clorox stock</a> inched 0.2% lower overnight, heading into Monday.&nbsp;</p><p>Hershey trades at a 30% discount to Lash’s $230 fair value estimate. Morningstar believes product innovation and marketing can help the chocolate maker defend its market position despite softer discretionary spending and consumer interest in healthier foods.</p><p>On Friday, BofA provided heft to Morningstar’s argument saying that though concerns about consumer staples remain ahead of third-quarter earnings, buying trends are starting to stabilize and investor sentiment has improved slightly from the previous quarter.&nbsp;</p><p><a href="https://stocktwits.com/symbol/HSY">Hershey stock</a> edged up 0.2% overnight after a 3.7% decline last week.&nbsp;</p><p>So far this year, KHC, CLX, and HSY stocks have declined 8% to 16%.&nbsp;</p><p>Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-mrna-hum-lite-stocks-surge-to-52-week-highs-last-week/cZx4wjZRBFQ">Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 In this photo illustration, a bottle of Heinz tomato ketchup is displayed next to a box of Kraft Mac & Cheese.

Consumer defensive stocks lagged the broader market in the third quarter, but Morningstar sees value in the sector as valuations remain attractive. Kraft Heinz (KHC), Clorox Co. (CLX) and Hershey Co. (HSY) stand out as top picks, trading at discounts of 4

KHC, CLX, HSY Stocks In Focus: Consumer Staples Lag The Market, But Analyst Sees Potential In These Three Names

Morningstar sees room for food, beverage and household product stocks to rise as companies adjust to consumers spending less. 


Clorox Co.

Hershey Company

Consumer Staples Select Sector SPDR Fund

Track KHC stock price, charts, news and real-time market activity on Stocktwits. Join the KHC message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Kraft Heinz Co stock.

KHC Stock Price Today - Kraft Heinz Co News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$24.34
Prev Close	$23.90
Open	$24.50
Dividend Yield	6.63%
50-Day Moving Average	$24.04
Beta	0.15
Avg. Volume	21.86M
PE Ratio	-8.50

52-Week High	$28.09
52-Week Low	$21.04
Market Capitalization	$28.86B
EPS (Annual)	-$4.93
Price to Book	0.80
Revenue Per Employee	$712,628.57

Feed

News

Sentiment

Earnings

Fundamentals

Info

KHC Fundamentals